 |
PDBsum entry 1f8p
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Mol Biol
305:307-329
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
|
|
R.Bader,
A.Bettio,
A.G.Beck-Sickinger,
O.Zerbe.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The biological importance of the neuropeptide Y (NPY) has steered a number of
investigations about its solution structure over the last 20 years. Here, we
focus on the comparison of the structure and dynamics of NPY free in solution to
when bound to a membrane mimetic, dodecylphosphocholine (DPC) micelles, as
studied by 2D (1)H NMR spectroscopy. Both, free in solution and in the
micelle-bound form, the N-terminal segment (Tyr1-Glu15) is shown to extend like
a flexible tail in solution. This is not compatible with the PP-fold model for
NPY that postulates backfolding of the flexible N terminus onto the C-terminal
helix. The correlation time (tau(c)) of NPY in aqueous solution, 5.5 (+/-1.0) ns
at 32 degrees C, is only consistent with its existence in a dimeric form.
Exchange contributions especially enhancing transverse relaxation rates (R(2))
of residues located on one side of the C-terminal helix of the molecule are
supposed to originate from dimerization of the NPY molecule. The dimerization
interface was directly probed by looking at (15)N-labeled NPY/spin-labeled
[TOAC34]-[(14)N]-NPY heterodimers and revealed both parallel and anti-parallel
alignment of the helices. The NMR-derived three-dimensional structure of
micelle-bound NPY at 37 degrees C and pH 6.0 is similar but not identical to
that free in solution. The final set of 17 lowest-energy DYANA structures is
particularly well defined in the region of residues 21-31, with a mean pairwise
RMSD of 0.23 A for the backbone heavy atoms and 0.85 A for all heavy atoms. The
combination of NMR relaxation data and CD measurements clearly demonstrates that
the alpha-helical region Ala18-Thr32 is more stable, and the C-terminal
tetrapeptide becomes structured only in the presence of the phosphocholine
micelles. The position of NPY relative to the DPC micelle surface was probed by
adding micelle integrating spin labels. Together with information from (1)H,(2)H
exchange rates, we conclude that the interaction of NPY with the micelle is
promoted by the amphiphilic alpha-helical segment of residues Tyr21-Thr32. NPY
is located at the lipid-water interface with its C-terminal helix parallel to
the membrane surface and penetrates the hydrophobic interior only via insertions
of a few long aliphatic or aromatic side-chains. From these data we can
demonstrate that the dimer interface of neuropeptide Y is similar to the
interface of the monomer binding to DPC-micelles. We speculate that binding of
the NPY monomer to the membrane is an essential key step preceeding receptor
binding, thereby pre-orientating the C-terminal tetrapeptide and possibly
inducing the bio-active conformation.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.R.Robertson,
S.P.Flynn,
H.S.White,
and
G.Bulaj
(2011).
Anticonvulsant neuropeptides as drug leads for neurological diseases.
|
| |
Nat Prod Rep,
28,
741-762.
|
 |
|
|
|
|
 |
D.N.Langelaan,
and
J.K.Rainey
(2010).
Membrane catalysis of peptide-receptor binding.
|
| |
Biochem Cell Biol,
88,
203-210.
|
 |
|
|
|
|
 |
G.Vauquelin,
and
S.J.Charlton
(2010).
Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action.
|
| |
Br J Pharmacol,
161,
488-508.
|
 |
|
|
|
|
 |
S.L.Pedersen,
P.G.Sasikumar,
S.Chelur,
B.Holst,
A.Artmann,
K.J.Jensen,
and
N.Vrang
(2010).
Peptide hormone isoforms: N-terminally branched PYY3-36 isoforms give improved lipid and fat-cell metabolism in diet-induced obese mice.
|
| |
J Pept Sci,
16,
664-673.
|
 |
|
|
|
|
 |
A.Szczuka,
M.Wennerberg,
A.Packeu,
and
G.Vauquelin
(2009).
Molecular mechanisms for the persistent bronchodilatory effect of the beta2-adrenoceptor agonist salmeterol.
|
| |
Br J Pharmacol,
158,
183-194.
|
 |
|
|
|
|
 |
L.Thomas,
H.A.Scheidt,
A.Bettio,
A.G.Beck-Sickinger,
D.Huster,
and
O.Zschörnig
(2009).
The interaction of neuropeptide Y with negatively charged and zwitterionic phospholipid membranes.
|
| |
Eur Biophys J,
38,
663-677.
|
 |
|
|
|
|
 |
M.Haack,
and
A.G.Beck-Sickinger
(2009).
Towards understanding the free and receptor bound conformation of neuropeptide Y by fluorescence resonance energy transfer studies.
|
| |
Chem Biol Drug Des,
73,
573-583.
|
 |
|
|
|
|
 |
C.K.Wang,
H.J.Schirra,
and
D.J.Craik
(2008).
NMRDyn: a program for NMR relaxation studies of protein association.
|
| |
PLoS ONE,
3,
e3820.
|
 |
|
|
|
|
 |
C.Xiao,
Y.Huang,
M.Dong,
J.Hu,
S.Hou,
F.J.Castellino,
M.Prorok,
and
Q.Dai
(2008).
NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins.
|
| |
Neuropeptides,
42,
601-609.
|
 |
|
|
|
|
 |
A.Neumoin,
B.Arshava,
J.Becker,
O.Zerbe,
and
F.Naider
(2007).
NMR studies in dodecylphosphocholine of a fragment containing the seventh transmembrane helix of a G-protein-coupled receptor from Saccharomyces cerevisiae.
|
| |
Biophys J,
93,
467-482.
|
 |
|
|
|
|
 |
N.Merten,
D.Lindner,
N.Rabe,
H.Römpler,
K.Mörl,
T.Schöneberg,
and
A.G.Beck-Sickinger
(2007).
Receptor subtype-specific docking of Asp6.59 with C-terminal arginine residues in Y receptor ligands.
|
| |
J Biol Chem,
282,
7543-7551.
|
 |
|
|
|
|
 |
M.Dyck,
A.Kerth,
A.Blume,
and
M.Lösche
(2006).
Interaction of the neurotransmitter, neuropeptide Y, with phospholipid membranes: infrared spectroscopic characterization at the air/water interface.
|
| |
J Phys Chem B,
110,
22152-22159.
|
 |
|
|
|
|
 |
M.Dyck,
and
M.Lösche
(2006).
Interaction of the neurotransmitter, neuropeptide Y, with phospholipid membranes: film balance and fluorescence microscopy studies.
|
| |
J Phys Chem B,
110,
22143-22151.
|
 |
|
|
|
|
 |
R.Sankararamakrishnan
(2006).
Recognition of GPCRs by peptide ligands and membrane compartments theory: structural studies of endogenous peptide hormones in membrane environment.
|
| |
Biosci Rep,
26,
131-158.
|
 |
|
|
|
|
 |
S.Jurt,
A.Aemissegger,
P.Güntert,
O.Zerbe,
and
D.Hilvert
(2006).
A photoswitchable miniprotein based on the sequence of avian pancreatic polypeptide.
|
| |
Angew Chem Int Ed Engl,
45,
6297-6300.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Lucyk,
H.Taha,
H.Yamamoto,
M.Miskolzie,
and
G.Kotovych
(2006).
NMR conformational analysis of proadrenomedullin N-terminal 20 peptide, a proangiogenic factor involved in tumor growth.
|
| |
Biopolymers,
81,
295-308.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.E.Herbig,
K.Weller,
U.Krauss,
A.G.Beck-Sickinger,
H.P.Merkle,
and
O.Zerbe
(2005).
Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides.
|
| |
Biophys J,
89,
4056-4066.
|
 |
|
|
|
|
 |
N.Pradeille,
O.Zerbe,
K.Möhle,
A.Linden,
and
H.Heimgartner
(2005).
The first total synthesis of the peptaibol hypomurocin A1 and its conformation analysis: an application of the 'azirine/oxazolone method'.
|
| |
Chem Biodivers,
2,
1127-1152.
|
 |
|
|
|
|
 |
R.Bader,
and
O.Zerbe
(2005).
Are hormones from the neuropeptide Y family recognized by their receptors from the membrane-bound state?
|
| |
Chembiochem,
6,
1520-1534.
|
 |
|
|
|
|
 |
H.Li,
F.Li,
Z.M.Qian,
and
H.Sun
(2004).
Structure and topology of the transmembrane domain 4 of the divalent metal transporter in membrane-mimetic environments.
|
| |
Eur J Biochem,
271,
1938-1951.
|
 |
|
|
|
|
 |
M.Miskolzie,
and
G.Kotovych
(2003).
The NMR-derived conformation of neuropeptide AF, an orphan G-protein coupled receptor peptide.
|
| |
Biopolymers,
69,
201-215.
|
 |
|
|
|
|
 |
R.von Eggelkraut-Gottanka,
Z.Machova,
E.Grouzmann,
and
A.G.Beck-Sickinger
(2003).
Semisynthesis and characterization of the first analogues of pro-neuropeptide y.
|
| |
Chembiochem,
4,
425-433.
|
 |
|
|
|
|
 |
S.T.Hsu,
E.Breukink,
G.Bierbaum,
H.G.Sahl,
B.de Kruijff,
R.Kaptein,
N.A.van Nuland,
and
A.M.Bonvin
(2003).
NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles. Conformational changes are a key to antimicrobial activity.
|
| |
J Biol Chem,
278,
13110-13117.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Bettio,
M.C.Dinger,
and
A.G.Beck-Sickinger
(2002).
The neuropeptide Y monomer in solution is not folded in the pancreatic-polypeptide fold.
|
| |
Protein Sci,
11,
1834-1844.
|
 |
|
|
|
|
 |
A.Bettio,
V.Gutewort,
A.Pöppl,
M.C.Dinger,
O.Zschörnig,
A.Klaus,
C.Toniolo,
and
A.G.Beck-Sickinger
(2002).
Electron paramagnetic resonance backbone dynamics studies on spin-labelled neuropeptide Y analogues.
|
| |
J Pept Sci,
8,
671-682.
|
 |
|
|
|
|
 |
A.L.Ulfers,
A.Piserchio,
and
D.F.Mierke
(2002).
Extracellular domains of the neurokinin-1 receptor: structural characterization and interactions with substance P.
|
| |
Biopolymers,
66,
339-349.
|
 |
|
|
|
|
 |
A.Bettio,
and
A.G.Beck-Sickinger
(2001).
Biophysical methods to study ligand-receptor interactions of neuropeptide Y.
|
| |
Biopolymers,
60,
420-437.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |